“The goal is not to validate every line of code—but to ensure every critical process works as intended and stands up to regulatory scrutiny.” — Adapted from GAMP® 5 philosophy.
The ISPE GAMP® 5 Guide: A Risk-Based Approach to Compliant GxP Computerized Systems Second Edition aims to protect patient safety, ISPE | International Society for Pharmaceutical Engineering GAMP Training Courses | ISPE - ISPE ispe gamp 5 training
All computerized systems must ensure data is: “The goal is not to validate every line
| Module | Key Topics | |--------|-------------| | | FDA/EU requirements, 21 CFR Part 11, data integrity (ALCOA+). | | The GAMP® 5 Life Cycle | From concept to retirement: V-model, specification, configuration, verification. | | Risk-Based Approach | Using risk assessment to determine validation effort and testing depth. | | Software Categories | Infrastructure (1), Non-Configurable (3), Configurable (4), Custom (5)—and how to validate each. | | Supplier Management | Assessing commercial off-the-shelf (COTS) software, supplier audits, documentation. | | Verification & Testing | Unit, integration, and user acceptance testing (UAT) strategies. | | System Retirement | Data migration, archiving, and system decommissioning. | | | Risk-Based Approach | Using risk assessment
In the highly regulated world of pharmaceuticals, biotechnology, and medical devices, computer systems validation isn’t just a technical necessity—it’s a regulatory mandate. The (Good Automated Manufacturing Practice) has emerged as the global gold standard for ensuring that computerized systems are fit for use and compliant with regulations like FDA 21 CFR Part 11 and EU Annex 11.